09Sep 2023
Google Trends Reveals Comparative Search Popularity of Five Advanced Prostate Cancer Medications

Google Trends Reveals Comparative Search Popularity of Five Advanced Prostate Cancer Medications

A recent study examining the public interest in FDA-approved drugs for advanced prostate cancer (PC) has unveiled intriguing findings. Following FDA approvals, drugs like abiraterone, enzalutamide, and apalutamide saw rapid spikes in popularity. Notably, over the past five years, enzalutamide and abiraterone garnered the most attention, with bicalutamide closely following in third place. The study also unveiled a correlation between states' Medicaid expansion decisions and drug search preferences. A connection was found between higher bicalutamide search indices, lower household income, and a greater percentage of uninsured adults across all states studied.

  • #urology

Like

Save

Share